Prototype to first revenue for funded device and diagnostics companies. Regulatory pathway, reimbursement, IP and go-to-market, handled by one senior operator on a fixed fee.
Most of my clients are one to fifty people. They have non-dilutive funding or a seed round, a working prototype, deep technical talent, and nobody whose job is getting the thing sold.
That is a solvable problem, and it is the one I have spent twenty-five years on. Most of it comes down to questions with real answers: who actually pays, what the pathway costs in time and money, and which ten customers are reachable first. Those answers exist. Getting to them takes an operator, not a consultant.
Fixed fee, scoped up front, priced in public. You will know what it costs before you get on the phone with me.
$18,000 – $25,000
Fixed fee · 3 weeks
One document that turns regulatory pathway, reimbursement strategy, IP position and first-market entry into a single plan with dates and owners.
Doubles as the commercialization plan an SBIR Phase II application requires.
$10,000 – $16,000/mo
2 days per week · 3-month minimum
Senior commercial leadership on your team without the search, the equity, or the fully loaded cost of a full-time executive.
Most engagements run three to nine months and end with a hire.
$25,000 – $40,000
Fixed fee · 4 to 6 weeks
I install the AI workflows I run my own practice on inside your company, and train your team to keep them running after I leave.
For teams who keep hearing they should use AI and have never been shown how.
Fixed fee, never hourly. Hourly billing penalises speed, and speed is the thing I am actually selling.
| Company | Years | What I did |
|---|---|---|
| Smart Human Dynamics | 2014 – 2026 | Founder and CEO. AI-enabled remote patient monitoring and wearables. Mayo Clinic partnership and investment, NIH SBIR with the University of Michigan, IRB clinical trials, and five issued patents on which I am sole inventor. |
| Bespoke Innovations / 3D Systems | 2012 – 2014 | Senior Director, Marketing and Business Development. Built a national direct and distributor channel from zero. |
| Spiracur | 2009 – 2012 | Wound care. Office-based go-to-market built on reimbursement codes that already existed, which is the fastest revenue path a device company ever gets. |
| Guidant → Abbott | 2001 – 2006 | Endovascular and vascular intervention, then the bioabsorbable stent program that carried into Abbott. Named inventor on twelve patents from that work. |
| Advisory | Selected | Materna, Volcano, Abbott, Amaranth, Innospine, Luma, HX Diagnostics. |
I have been the founder writing the SBIR application, the executive presenting to the board, and the marketer standing in an operating room at six in the morning. I have raised money, run trials, prosecuted patents and closed first customers.
I am also unusually far along with AI tooling, and do the majority of my work through it now. That is why I can sell fixed-fee engagements at speeds that used to require a team. It is a delivery advantage, not a product pitch. I am a commercialization operator who happens to be AI-native.
Based in Lafayette, California. Bay Area companies in person, everyone else remotely.
Thirty minutes, no charge, no deck. Bring your situation and I will tell you what I would do first, whether or not you hire me.